Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial

Yalcin S., Uslu R., Dane F., Yilmaz U., Zengin N., Buyukunal E., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.15, 2011 (SCI-Expanded) identifier